Bioqual (OTCMKTS:BIOQ) Posts Earnings Results

Bioqual (OTCMKTS:BIOQGet Free Report) posted its quarterly earnings data on Tuesday. The company reported ($1.36) EPS for the quarter, Zacks reports. Bioqual had a negative net margin of 5.54% and a negative return on equity of 7.37%.

Bioqual Trading Down 0.8 %

OTCMKTS:BIOQ opened at $62.00 on Thursday. The stock has a 50-day simple moving average of $66.35 and a 200 day simple moving average of $68.40. Bioqual has a one year low of $62.00 and a one year high of $80.00.

About Bioqual

(Get Free Report)

Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.

Featured Articles

Earnings History for Bioqual (OTCMKTS:BIOQ)

Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.